An ABA practice marketing claim substantiation workflow inventories each express and implied claim about services, credentials, network status, access, cost, availability, outcomes, comparisons, safety, evidence, or technology before publication. It identifies the audience and placement, assigns an evidence standard and qualified reviewer, records needed qualifications, approves exact language, monitors changing facts, and corrects or retires claims when support, scope, or context changes.

Define the claim substantiation workflow

Farah reviews words, images, charts, demonstrations, page titles, snippets, calls to action, staff scripts, and omissions that can change the overall message. She separates a factual directory statement from a clinical, health, safety, cost, network, or comparative claim requiring different evidence and authority. The claim-to-evidence register has a named owner, entity and channel scope, current sources, qualified decision boundaries, versions, dates, role-limited access, evidence locations, exception routes, correction paths, retention sources, and legal-hold state.

Capture the fields needed for review

The working record captures claim ID and exact language, implied message, audience, channel and placement, service and entity, geography and date, clinical or operational owner, claim type, evidence standard, source and population, methods and limits, qualification and disclosure, credential or network source, price assumptions, availability window, reviewer, approval, expiry, monitoring trigger, correction, affected placements, archive, and evidence. Structured fields make audiences, claims, relationships, permissions, sources, dates, money, data, evidence, and status searchable. Narrative explains a disputed message or context while source assets, authorizations, agreements, approvals, and platform evidence remain intact.

Apply the substantiation method

She requires support before dissemination, ties the proof to the same claim and audience, and puts material qualifications near the claim in usable language. A testimonial, guarantee, disclaimer, or link cannot supply evidence for an unsupported headline. Time-sensitive claims carry a refresh date and source owner.

Keep marketing states separate

Farah distinguishes audience, claim, evidence, approval, publication, inquiry, referral, intake, clinical review, conditional offer, authorization, service, claim, adjudication, payment, review, complaint, and correction. A published message never establishes clinical appropriateness, consent, payer coverage, capacity, outcome, or payment.

Control changes and urgent corrections

Farah routes changed claims, sources, people, permissions, payers, locations, services, prices, availability, images, channels, agencies, accounts, tracking, and platform rules to affected owners. An urgent hold records the asset, reason, owner, interim action, affected placements, evidence preservation, correction, confirmation, and follow-up review.

Validate the workflow in context

Farah tests outcome percentages, speed, wait time, cost, insurance, credentials, evidence-based language, safety, family satisfaction, technology, comparisons, guarantees, and map availability. She checks mobile, search, social, directory, event, and intake-script context.

Separate operational facts from outcome evidence

Farah can verify a location, phone number, licensed role, published service, or current appointment block from an authoritative operational source. A claim about clinical benefit, safety, diagnostic effect, symptom change, or typical result needs evidence suited to that claim. An internal dashboard may describe the observed cohort while still lacking design, comparison, measurement validity, or generalizability needed for a broader advertisement. She routes clinical interpretation to qualified reviewers and states the population, period, denominator, collection method, missing data, limits, and source date before deciding whether any public wording is supportable.

Reconcile public messages with source systems

Farah compares public claims and activity with credentials, payer records, service definitions, schedules, locations, contracts, permissions, platform settings, inquiry records, invoices, complaints, and correction evidence. Each discrepancy retains audience, period, people, money, privacy or access effect, owner, due date, and supported disposition.

Protect clinical and family decision rights

Farah keeps assessment, diagnosis, treatment, supervision, risk, discharge, and documentation decisions with qualified professionals and preserves family choice, privacy, access, assent when applicable, and complaint rights. Marketing staff can explain supported facts and route questions; they cannot promise care, coverage, outcomes, clinical approval, or priority outside the approved workflow.

Work through Farah's fictional example

Farah locks 24 proposed claims. Eighteen have exact language, implied message, evidence, limits, reviewer, placement, expiry, and monitoring. One outcome claim uses the wrong population, one network claim is stale, two availability claims lack dates, one comparison lacks a basis, and one disclaimer is too distant. Four claims are repaired. Two remain held. This synthetic example tests claims, permissions, relationships, data, and denominator logic. It offers no legal, advertising, privacy, clinical, payer, referral, accessibility, security, or platform conclusion about a real practice.

Calculate measures with stable denominators

Initial claim integrity is 18 of 24, or 75.0%. Twenty-two claims validate, or 91.7%. Claims, evidence items, placements, approvals, corrections, and held claims retain separate counts.

Address the main marketing claim substantiation workflow risk

A true data point can become a misleading claim when the population, period, comparison, or placement changes. Farah reviews the complete message in context.

Test the artifact against hard cases

Farah tests outcome, wait time, cost, network, credential, evidence claim, safety, satisfaction, technology, comparison, guarantee, and availability map. Each case records entity, audience, source, relationship, claim, permission, channel, money, data, review, exception, correction, validation result, and next review.

Close review with unresolved work visible

Farah confirms claims, sources, permissions, disclosures, relationships, access, data, accounts, placements, monitoring, complaints, corrections, and fresh validation. The marketing claim substantiation workflow stays in draft until every named reviewer finishes. Open work retains owner, age, affected audience, interim safeguard, and next action.

Ground the marketing control in ABA organizational context

Farah uses the CASP Organizational Guidelines public overview for high-level business-operations, clinical-operations, and risk-management context. CASP sells the detailed guidelines. This marketing claim substantiation workflow is an editorial operating control pending the named advertising, privacy, clinical, payer, family, accessibility, compliance, security, and legal reviews.

Substantiate objective claims before release

The FTC Advertising FAQs says advertisers need a reasonable basis before running a claim and that health or safety claims generally require competent and reliable scientific evidence. It also says testimonials cannot supply support for claims requiring objective evaluation. Farah ties each message to evidence suited to the exact audience, wording, context, and date.

Treat health-related evidence with care

The FTC Health Products Compliance Guidance describes how express and implied health claims, the overall advertisement, disclosure placement, and the fit between evidence and claim affect evaluation. Farah uses it as advertising guidance, not as clinical authority or proof that a particular ABA claim is supported.

Make endorsements honest and connections visible

The FTC Endorsement Guides Q&A says endorsements must be honest and must not communicate a claim the marketer could not lawfully make. It also addresses clear and conspicuous disclosure of unexpected material connections. Farah reviews the endorser's real experience, the relationship, the claim, the disclosure, and the final placement.

Apply the current consumer-review rule

The FTC Consumer Reviews and Testimonials Rule Q&A says the rule took effect October 21, 2024 and addresses specified fake or false reviews and testimonials, sentiment-conditioned incentives, insider practices, suppression, controlled review sites, and fake influence indicators. Staff guidance is not a safe harbor. Farah records the real solicitation, incentive, vendor, response, and platform facts for qualified review.

Classify HIPAA marketing before using PHI

HHS's HIPAA marketing guidance explains that the Privacy Rule generally requires authorization for uses or disclosures of PHI for marketing, subject to defined exceptions. Farah first determines entity, data, purpose, communication, payment, and exception status. Service consent, a testimonial release, media permission, and HIPAA authorization remain distinct.

Map agency and platform relationships

HHS's current Business Associates guidance explains BAA requirements for covered entity to business associate and business associate to subcontractor relationships. Farah maps whether an agency, call tracker, platform, creator, or vendor creates, receives, maintains, or transmits PHI for regulated work. A BAA constrains permitted activity; it does not authorize marketing that the Privacy Rule forbids.

Minimize marketing data and access

The FTC personal-information guide recommends inventory, minimization, least-privilege access, security, retention policy, secure disposal, and incident planning. Farah applies those concepts to leads, pixels, call recordings, lists, images, permissions, accounts, analytics, and agency exports while purpose, privacy, contract, and legal-hold sources remain active.

Review referral relationships within healthcare compliance

The OIG General Compliance Program Guidance is voluntary and nonbinding and discusses compliance-program infrastructure and federal healthcare risk. Farah uses it to support disclosure, oversight, reporting, auditing, and correction while counsel analyzes actual referral, compensation, gift, federal-program, payer, state-law, and professional facts.

Keep public access duties in the release gate

The DOJ Title III overview describes equal opportunity, reasonable modifications, effective communication, and physical-access duties for covered public accommodations, subject to rule-specific standards and defenses. Farah routes affected services, events, policies, forms, communications, and facilities through qualified accessibility review.

Test the digital path for accessibility

The DOJ web-accessibility guidance explains that inaccessible web content can limit access to goods, services, and privileges offered by public accommodations. Farah tests the real mobile and desktop journey, including navigation, forms, media, documents, errors, contact routes, and third-party components, while qualified specialists determine applicable standards and remediation.

Related resources

Sources